 BOSTON, March 24, 2022 GLOBE NEWSWIRE -- Akouos, Inc. Akouos NASDAQ: AKUS, a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, today announced that Manny Simons, Ph.D., M.B.A., co-founder, president, and chief executive officer will participate in two upcoming virtual investor conferences in March: 